The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial

BACKGROUND: The promotility agents currently available to treat gastroparesis and feed intolerance in the critically ill are limited by adverse effects. The aim of this study was to assess the pharmacodynamic effects and pharmacokinetics of single doses of the novel gastric promotility agent motilin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Crit Care
Main Authors: Chapman, Marianne J., Deane, Adam M., O’Connor, Stephanie L., Nguyen, Nam Q., Fraser, Robert J. L., Richards, Duncan B., Hacquoil, Kimberley E., Vasist Johnson, Lakshmi S., Barton, Matthew E., Dukes, George E.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4967996/
https://ncbi.nlm.nih.gov/pubmed/27476581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1420-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados